{
    "clinical_study": {
        "@rank": "132938", 
        "arm_group": {
            "arm_group_label": "Stem Cells", 
            "arm_group_type": "Experimental", 
            "description": "autologous bone marrow mononuclear cell transplantation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to study the safety and effect of stem cell therapy on the\n      functional recovery in patients with chronic stroke."
        }, 
        "brief_title": "Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Cerebrovascular Accident", 
        "condition_browse": {
            "mesh_term": [
                "Cerebral Infarction", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  males and females\n\n          -  above 18 years of age\n\n          -  diagnosed as stroke by clinical and MRI findings\n\n        Exclusion Criteria:\n\n          -  presence of respiratory distress\n\n          -  presence of acute infections such as Human Immunodeficient Virus/Hepatitis B\n             Virus/Hepatitis C Virus\n\n          -  malignancies\n\n          -  acute medical conditions such as respiratory infection, fever\n\n          -  hemoglobin less than 8\n\n          -  bleeding tendency\n\n          -  bone marrow disorder\n\n          -  left ventricular ejection fraction < 30%\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065778", 
            "org_study_id": "NGBSI-08"
        }, 
        "intervention": {
            "arm_group_label": "Stem Cells", 
            "description": "bone marrow derived mononuclear cells are administered intrathecally in chronic stroke patients", 
            "intervention_name": "Autologous bone marrow mononuclear cell transplantation", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "400071"
                }, 
                "name": "Neurogen brain and spine institute"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Clinical Study of Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke", 
        "overall_official": {
            "affiliation": "Neurogen Brain and Spine Institute", 
            "last_name": "Alok K Sharma, M.S., M.Ch", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Functional Independence Measure", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": {
            "PMID": "21727900", 
            "citation": "Borlongan CV. Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Leukemia. 2011 Nov;25(11):1674-86. doi: 10.1038/leu.2011.167. Epub 2011 Jul 5. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065778"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Neurogen Brain and Spine Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neurogen Brain and Spine Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2008", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}